Clinical Trial Detail

NCT ID NCT02508246
Title AZD1775, Docetaxel, and Cisplatin Before Surgery in Treating Patients With Borderline Resectable Stage III-IVB Squamous Cell Carcinoma of the Head and Neck
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Washington
Indications

head and neck squamous cell carcinoma

Therapies

Adavosertib

Docetaxel

Cisplatin

Age Groups: adult

No variant requirements are available.